OXON’s COVID-19 Research Programme
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
Understanding Health Care in Germany is our upcoming webinar. Registration is open for professionals in Pharma companies willing to learn about how to conduct observational studies in this scenario.
The Nordics is within OXON’s 2019/20 webinar series to help understand health care for conducting optimal observational studies.
22nd – 23rd May 2019,
Holiday Inn London Kensington Hotel, London UK
Nawab Qizilbash, Head of OXON, will be speaking about PASS Studies.
The third of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
The second of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
A webinar series from leading national pharmacoepidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.